FDA’s Vaccine Panel Questions The Sustainability Of Our Covid-19 Strategy In a palpably concerned forum, the FDA panel members could be seen calculating the human expense of an untenable vaccine strategy where we now have an every-four-month booster effort. It became evident that the VRBPAC vision of pandemic resolution was no longer focused just through vaccine eyes.